Viability and functionality of cells delivered from peptide conjugated scaffolds

Biomaterials

Volumn 32, Issue 15, 2011, Pages 3721-3728

  Vacharathit, Voranaddha ^a   Silva, Eduardo A ^a   Mooney, David J ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Alginate; Angiogenesis; Biomimetic material; Cell activation; Cell adhesion; RGD peptide

Indexed keywords

ALGINATE SCAFFOLDS; ANGIOGENESIS; CELL ACTIVATION; CELL DELIVERY; CELL THERAPY; CELL-BASED THERAPY; CELLULAR MIGRATION; CYTOKINES; FUNCTIONAL CELLS; MATERIAL SYSTEMS; MICROENVIRONMENTS; RE-INTEGRATION; RGD PEPTIDE; SURFACE MARKERS;

ADHESION; ALGINATE; BIOMIMETICS; CELL ADHESION; CELL DEATH; ENDOTHELIAL CELLS; PEPTIDES; TISSUE;

SCAFFOLDS (BIOLOGY);

ALGINIC ACID; ANGIOGENIC FACTOR; ARGINYLGLYCYLASPARTIC ACID; CELL SURFACE MARKER; CYTOKINE; MOLECULAR SCAFFOLD;

ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL DENSITY; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CELL STRUCTURE; CELL VIABILITY; CYTOKINE RELEASE; ENDOTHELIUM CELL; OUTGROWTH ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGOPEPTIDES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 79952764288     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.12.048     Document Type: Article

References (29)

1. Hofmann M., Wollert K.C., Meyer G.P., Menke A., Arseniev L., Hertenstein B., et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005, 111:2198-2202.
2. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006, 355:1199-1209.
3. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006, 355:1210-1221.
4. Menasché P. Cellular therapy in cardiology. C R Biol 2007, 330(6-7):550-556.
5. Mansour S., Roy D.C., Lemieux B., Ouellet C., Stevens L.M., Noiseux N. Stem cell therapy for the broken heart: mini-organ transplantation. Transplant Proc 2009, 41(8):3353-3357.
6. Chen F.M., Zhang M., Wu Z.F. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010, 31:6279-6308.
7. Nehls V., Herrmann R., Huhnken M. Guided migration as a novel mechanism of capillary network remodeling is regulated by basic fibroblast growth factor. Histochem Cell Biol 1998, 109:319-329.
8. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676.
9. Johnson P.C., Mikos A.G., Fisher J.P., Jansen J.A. Strategic directions in tissue engineering. Tissue Eng 2007, 13:2827-2837.
10. Hiatt W.R. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001, 344:1608-1621.
11. Hou D., Youssef E.A., Brinton T.J., Zhang P., Rogers P., Price E.T., et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005, 112:I150-I156.
12. Silva E.A., Kim E.S., Kong H.J., Mooney D.J. Material-based deployment enhances efficacy of endothelial progenitor cells. PNAS 2008, 105:14347-14352.
13. Tonnesen H.H., Karlsen J. Alginate in drug delivery systems. Drug Dev Ind Pharm 2002, 28:621-630.
14. Bouhadir K.H., Lee K.Y., Alsberg E., Damm K.L., Anderson K.W., Mooney D.J. Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog 2001, 17:945-950.
15. Draget K.I., Skjåk-Braek G., Smidsrød O. Alginate based new materials. Int J Biol Macromol 1997, 21(1-2):47-55.
16. Thornton A.J., Alsberg E., Albertelli M., Mooney D.J. Shape-defining scaffolds for minimally invasive tissue engineering. Transplantation 2004, 77:1798-1803.
17. Rowley J.A., Mooney D.J. Alginate type and RGD density control myoblast phenotype. J Biomed Mater Res 2002, 60:217-223.
18. Alsberg E., Anderson K.W., Albeiruti A., Franceschi R.T., Mooney D.J. Cell-interactive alginate hydrogels for bone tissue engineering. J Dent Res 2001, 80(11):2025-2029.
19. Ingram D.A., Mead L.E., Tanaka H., Meade V., Fenoglio A., Mortell K., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760.
20. Boontheekul T., Kong H.J., Mooney D.J. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials 2005, 26:2455-2465.
21. Rowley J.A., Madlambayan G., Mooney D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999, 20:45-53.
22. Palecek S.P., Loftus J.C., Ginsberg M.H., Lauffenburger D.A., Horwitz A.F. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature 1997, 385(6616):537-540.
23. Stéphanou A., Meskaoui G., Vailhé B., Tracqui P. The rigidity in fibrin gels as a contributing factor to the dynamics of in vitro vascular cord formation. Microvasc Res 2007, 73(3):182-190.
24. Cameliet P. Angiogenesis in life, disease, and medicine. Nature 2005, 438:932-936.
25. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001, 19:1029-1034.
26. Zhuge X., Murayama T., Arai H., Yamauchi R., Tanaka M., Shimaoka T., et al. CXCL16 is a novel angiogenic factor for human umbilical vein endothelial cells. Biochem Biophys Res Commun 2005, 331(4):1295-1300.
27. Salcedo R., Ponce M.L., Young H.A., Wasserman K., Ward J.M., Kleinman H.K., et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000, 96(1):34-40.
28. Luttun A., Tjwa M., Moons L., Wu Y., Angelillo-Scherrer A., Liao F., et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002, 8:831-840.
29. Otrock Z.K., Mahfouz R.A.R., Makarem J.A., Shamseddine A.I. Understanding the biology of angiogenesis: review of the most important molecular mechanisms. Blood Cells Mol Dis 2007, 39(2):212-220.